Bedrood describes improved visualization of the ciliary body, efficient setup, and favorable postoperative outcomes. Sahar Bedrood, MD, PhD, discussed her early clinical experience with the Leos ...
Phase 2 STARLIGHT study participants, particularly those with the macular phenotype, experienced meaningful gains in visual acuity at 48 weeks. Kenneth C. Fan, MD, MBA, of Retina Consultants of Texas, ...
FALCON study involved 47 patients with ADOA across the US, UK, Italy, and Denmark, assessing disease progression over 24 months. Results showed slow progression of OPA1-associated ADOA, with 24% ...
AURN001 demonstrated a dose-dependent response, with the high-dose group achieving significant visual acuity improvements and a mean BCVA change of 12.5 letters. The therapy was well-tolerated across ...
Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...
Sunir J. Garg, MD, explores the nuances of endophthalmitis, distinguishing between infectious and non-infectious responses for effective patient management. Note: Video captions are generated with the ...
Research reveals significant vision improvements and extended treatment intervals with aflibercept 8 mg for age-related macular degeneration and diabetic edema patients. Note: Video captions are ...
Innovations in selective laser trabeculoplasty and laser cyclophotocoagulation focus on procedural efficiency, patient comfort, and evolving first-line treatment strategies.
Ophthalmologists from across the United States and around the globe gathered in Orlando, Florida over the October 17 through 20, 2025 to discuss advances in all areas of eye care. The American Academy ...
John P. Berdahl, MD, a surgeon at Vance Thompson Vision and a professor at the University of South Dakota, spoke on the lens implantation strategies for patients with pseudoexfoliation at the 2025 ...
The American Academy of Ophthalmology (AAO) is hosting its annual scientific meeting in Orlando, Florida from October 17 ...
Ophthalmology Times: What are the most striking differences in anatomic outcomes (GA lesion growth, photoreceptor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback